SA
Shifamed angel investors
Campbell, California, United StatesFounded 2007
Shifamed, a medical technology innovation hub, focuses its investments primarily on the cardiovascular space, developing next-generation medical devices. Their strategy involves a "fast follower" approach, aiming to improve upon existing solutions in established markets to reduce risk and build companies attractive for acquisition by major strategic players.
100% of their portfolio is in Healthcare. Their most common stage is series-b (67% of deals). Average disclosed round size is $34.2M (across 3 rounds with reported amounts).
Portfolio
3
Fund Size
$30M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
3 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Akura Medical | Series B | $35M | Oct 2023 |
 Tioga Cardiovascular | Series C | $30M | Feb 2023 |
 Adona Medical | Series B | $37.5M | Apr 2022 |
Top Co-Investors
The General Partnership3 shared
Cormorant Asset Management3 shared
PA MedTech VC fund3 shared
AMD Ventures3 shared
Lilly Asia Ventures1 shared
Excelestar Ventures1 shared
Last updated: 10 April 2026